PMP-1

N/A

Report date: 2025/06/11 11:07:16
NME

Base Information

Drug NamePMP-1
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsInsulin-like growth factor II receptor agonists
TargetsInsulin-like growth factor II receptor
Therapy Area/IndicationsAngelman Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesNew York University
Inactive CompaniesN/A
Active IndicationsAngelman Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A